Zoetis (ZTS) Other Working Capital Changes (2012 - 2026)
Zoetis (ZTS) posted quarterly Other Working Capital Changes of $66.0 million for Q1 2026, up 43.48% year-over-year from $46.0 million in Q1 2025, and up 760.0% quarter-over-quarter from -$10.0 million in Q4 2025.
Zoetis (ZTS) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Other Working Capital Changes for 15 consecutive years, with $66.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 43.48% year-over-year to $66.0 million; the TTM figure through Mar 2026 stood at $185.0 million (up 1333.33% YoY), while the FY2025 annual figure was $165.0 million, up 417.31% from the prior year.
- Other Working Capital Changes advanced to $66.0 million in Q1 2026 per ZTS's latest filing, from -$10.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $116.0 million in Q2 2025 and bottomed at -$66.0 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged $14.1 million across 5 years, with a median of $13.0 million in 2025.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 466.67% — and 2023, when it surged 2300.0%.
- Zoetis' Other Working Capital Changes stood at -$55.0 million in 2022, then surged by 56.36% to -$24.0 million in 2023, then sank by 175.0% to -$66.0 million in 2024, then jumped by 84.85% to -$10.0 million in 2025, then jumped by 760.0% to $66.0 million in 2026.
- Business Quant data shows ZTS's Other Working Capital Changes at $66.0 million in Q1 2026, -$10.0 million in Q4 2025, and $13.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 92.00 Mn |
| Jun 30, 2026 | 92.00 Mn |
| Jun 30, 2026 | 92.00 Mn |
| Mar 31, 2026 | 66.00 Mn |
| Mar 31, 2026 | 66.00 Mn |
| Mar 31, 2026 | 66.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -66.00 Mn |
| Dec 31, 2024 | -66.00 Mn |